B.A.M! - (((Buyouts, Acquisitions & Mergers)))

[Just the facts maam]

ANIP looks like it is getting bought out. Should much higher that current PPS.

They had three NDA's before the FDA but never told investors what they were for or the PDUFA dates. the first Tezruly was approved last week for an oral solution of terazosin. This looks like the first approved alpha-blocker in the world.

The second NDA with a decision out soon is likely for the FDA first female testosterone drug to treat HSDD. they may have 10 years safety and efficacy for this submission. A mid trial review showed it reduced the risk of post-menopausal women at risk of having a cardiovascular event by at least 70% and reduce risk of experiencing a breast cancer event by an undisclosed amount. The large study had 3,656 participants. Though ANIP submitted this NDA, it was paid for by another company. (Most likely the acquiring company)

The third NDA being reviewed is likely drug for the first oral liquid hydrochlorothiazide was submitted in Q1 2024. The info is buried in their 10-Q filing, but did not make it into their press release.

According to ANIP's FAQ the location of their head office has moved to 500 Alexander Park, Princeton, N.J, from Baudette, MN., It also says they have two US based manufacturing facilities. Where the corporate presentation shows that have three manufacturing plants. Looks like they sold a plant.

A search of Leadiq shows that none of the current senior executives are among leadership.

For the above reasons ANIP looks like it is being bought out and at a much higher price than it is trading at today.

Here are some links for those interested in finding out more.

https://seekingalpha.com/article/4709576-anip-stock-tezruly-approved-two-more-nda-review-alimera-acquisition-could-triple-revenue

https://investor.anipharmaceuticals.com/ir-resources/investor-faqs

https://leadiq.com/c/ani-pharmaceuticals-inc/5a1d8a9b240000240064666c/employee-directory?page=6